Advancements in antibody-drug conjugates transform cancer therapy
Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines the precision of monoclonal antibodies with the potency of cytotoxic drugs.
23 Oct 02:57 · News-Medical